In the near future, well see stronger doses of these treatments, and even new combined options for dual action, and in some cases, triple action results
Ozempic was already available for lowering the risk of major adverse cardiovascular events in patients with diabetes who have established cardiovascular disease and have obesity or overweight, with an initial body mass index (BMI) of 27 or greater
For a treatment that typically runs for months or longer, pricing predictability is not a small thing
We can't stress this enough: the reconstitution step is an active and critical part of your experimental procedure, not just a prep-work task to rush through
Bloodwork provides the objective data you need to confirm the stack is working safely and effectively
doi: 10.1111/j.1471-0528.2008.01902.x 272 PoonLCNicolaidesKH